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The TGF-
 
 
 
 family comprises many cytokines involved
in the control of cell fate (1). Some of these have been
shown to control cell death. For instance, at least one of
the members of the BMP subfamily of the TGF-
 
 
 
 family is
required in interdigital death, a classical model of develop-
mentally programmed cell death (2). Another TGF-
 
 
 
 fam-
ily member, TGF-
 
 
 
1, entertains a complicated relation-
ship with cell death, of lymphocytes in particular. When
added extracellularly, it has been reported to induce death
of B lymphocytes (3, 4) and to prevent T lymphocyte
death (5–7).
A new, and at times somewhat heretical twist, is now re-
ported (8). In mice homozygous for a TGF-
 
 
 
1 null muta-
tion (9, 10), thus not expressing TGF-
 
 
 
1, W.J. Chen et al.
(8) found that apparently spontaneous apoptosis of both
thymic and peripheral T cells was increased compared with
wild-type controls. These findings might seem relatively
trivial, since TGF-
 
 
 
1 had previously been shown to pre-
vent T cell death (see above). However, not only was
spontaneous T cell death impressive in both thymus and
peripheral organs, but results were even more striking
when T cells were challenged with anti-CD3 antibody
(mimicking stimulation through the TCR). In vitro exper-
iments already showed an increased sensitivity of T cells
from TGF-
 
 
 
1 knockout mice, resulting in marked activa-
tion-induced cell death. The most spectacular results were
obtained with in vivo injection of anti-CD3 antibody into
TGF-
 
 
 
1 knockout mice, leading to massive apoptosis in
both thymus and spleen, visible as terminal deoxynucleotidyl
transferase (TdT)-mediated dUTP-biotin nick end-label-
ing (TUNEL)-positive cells within hours, and effecting
considerable reduction in lymphoid organ cell numbers.
This was accompanied by an increase in expression of Fas
and Fas ligand in spleen cells, and increase in sensitivity to
the Fas pathway and in some situations to the TNFR2
pathway of cell death. These results demonstrated that acti-
vated lymphocytes in vivo require TGF-
 
 
 
1 to protect
them from death.
More surprising results followed (8). TGF-
 
 
 
1, and more
generally all members of the TGF-
 
 
 
 family, are known to
affect cells from the outside through cognate cell surface re-
ceptors, the engagement of which lead to intracellular acti-
vation of Smad transcription factors, especially Smad3 in
the case of TGF-
 
 
 
1 (1, 11, 12). However, the current
work (8) suggests that the protective effects of TGF-
 
 
 
1
might be due to intracellular TGF-
 
 
 
1. Two lines of evi-
dence support this. First, exogenous TGF-
 
 
 
 did not correct
the increased cell death observed in TGF-
 
 
 
1 knockout
cells. Of course, one could imagine that externally applied
TGF-
 
 
 
1 could be inactivated by secreted TGF-
 
 
 
 antago-
nists, of which there are many (11). These are very efficient
blockers when added externally as shown in the interdigital
cell death model mentioned above (13, 14), and might be
more so in the present TGF-
 
 
 
1 knockout situation where
these inhibitors would find no endogenous TGF-
 
 
 
1 to inter-
act with. However, most of the abnormal traits in TGF-
 
 
 
1
knockout mice are reversed or prevented by ingestion of ma-
ternal TGF-
 
 
 
1 during suckling, while interestingly the apop-
totic T cell phenotype is not. Second, no sensitization to cell
death similar to that observed in TGF-
 
 
 
1 knockout mice
was observed in mice inactivated for the Smad3 gene, ruling
out the participation of a Smad3 transduction pathway. In
line with this, Smad3
 
 
 
/
 
 
 
 mice showed normal develop-
ment of lymphocytes and increased proliferation and acti-
vation of T cells (15) within an abnormal phenotype which
seemed generally milder than TGF-
 
 
 
1
 
 
 
/
 
 
 
 (for a review,
see reference 11). The authors thus favor the interpretation
that TGF-
 
 
 
1 acts not only extracellularly via its cognate re-
ceptor and Smad3, but also intracellularly. As an alterna-
tive, one may hypothesize that TGF-
 
 
 
1 might act only ex-
tracellularly via its cognate receptor but be able to use, say,
another Smad than Smad3 (16). Definitive arguments in fa-
vor of an “intracrine” mechanism similar to that of e.g., fi-
broblast growth factor 2 (17) may require, for instance, ret-
roviral infection of TGF-
 
 
 
1
 
 
 
/
 
  
 
T cells with a construct
encoding a nonexportable TGF-
 
 
 
1 molecule. The postu-
late that TGF-
 
 
 
1 has an intracellular role suggests interest-
ing scenarios. Two sites of action are implied for TGF-
 
 
 
1
molecules, as a ligand for a cell-surface receptor, and as an
intracellularly active molecule, as well as two functions,
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aborting or triggering cell death. One wonders whether the
same site on the TGF-
 
 
 
1 molecule would be used in both
instances.
The evidence above suggests that in some cases TGF-
 
 
 
1
may act intracellularly to protect cells from death, in the
very cells that most probably synthesize it. If protection is
intracellular, then where does it take place and how? Mito-
chondria involvement is appealing, since mitochondria are
considered integrators for programmed cell death (18, 19).
It had previously been shown that TGF-
 
 
 
 can be found in
mitochondria (20, 21). This observation is now confirmed
and extended, using several techniques, such as organelle
fractionation followed by Western blot analyses and ELISA
tests, immunolocalization, and immunogold electron mi-
croscopy (8). What then could be the relationship between
mitochondrial localization of TGF-
 
 
 
, increased cell death
upon lack of TGF-
 
 
 
, and mitochondrial involvement in
cell death? Mitochondrial morphology seems to be altered
in TGF-
 
 
 
1 knockout cells (8). Also, in dying wild-type
cells mitochondria show modifications of their membrane
potential, believed to be essential at least in some cases for
the release of several proapoptotic factors. Cell death in-
duced through the lack of TGF-
 
 
 
 also shows a decrease in
mitochondrial membrane potential (8). This is regulated by
members of the Bcl-2 family such as the antiapoptotic
Bcl–XL molecule. While in wild-type T cells costimulation
through the TCR leads to an increase of Bcl–XL mRNA,
in TGF-
 
 
 
1 knockout T cells there is no such increase.
Although all these arguments are consistent with a role
for TGF-
 
 
 
1 within mitochondria, they are only correla-
tive. In particular, it is difficult to understand what relation-
ship may exist between the presence of TGF-
 
 
 
1 in mito-
chondria and the level of Bcl–XL mRNA in the cytoplasm;
the latter would be more readily explained via the classical
effect of TGF-
 
 
 
 receptors on Smad transcription factors.
Also, even when externally applied, TGF-
 
 
 
1 induces
hepatocyte apoptosis through the mitochondrial/Apaf-1
caspase activation pathway (22), downregulates Bcl-XL in a
rat prostate epithelial cell line which decreases its death
(23), and induces cell death in a variety of cell types in a
manner which is enhanced by the mitochondrially located
protein ARTS (24), showing that TGF-
 
 
 
1 need not reside
within the mitochondria to induce cell death through a
Bcl–XL- and ARTS-regulated mitochondrial pathway.
True, compared with the work of Chen et al., the latter
experiments did not deal with T cells, and externally ap-
plied TGF-
 
 
 
 induced rather than inhibited cell death. In
the situation described by Chen et al., TGF-
 
 
 
1 knockout
cells were more sensitive to death, showing that TGF-
 
 
 
 in
this case protects from cell death (8). It could be that exter-
nally applied TGF-
 
 
 
 induces cell death by affecting mito-
chondria indirectly, while TGF-
 
 
 
 located in mitochondria
might directly protect from cell death. However, it is not
excluded that TGF-
 
 
 
1, even if acting within the cell, ex-
erts its protective role primarily elsewhere than in the mi-
tochondria. TGF-
 
 
 
 can indeed be located also in other
subcellular sites (21).
Altogether, the current work of Chen et al. (8) demon-
strates that TGF-
 
 
 
1 strongly protects T lymphocytes from
cell death and provides provocative results possibly assign-
ing this protection to intracellular TGF-
 
 
 
1. It is tempting
to hypothesize that at least some of the protected cells are
those that produce TGF-
 
 
 
1.
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